Scholarlink

<p>Combining multidisciplinary care plans into integrated care pathways (ICPs) is scalable, generalizable and effective for several long-term conditions, but not evaluated in Long COVID (LC). Our phase 3, cluster-randomized, multicenter clinical trial investigated the effectiveness of ICP interventions for LC. Recruitment of adults ≥18 years with LC was conducted in 6 National Health Service LC clinics in England with specialist ICPs. The intervention arms were (i) multi-organ magnetic resonance imaging (MRI; Coverscan), (ii) digital rehabilitation (Living with COVID Recovery), (iii) both multi-organ MRI and digital rehabilitation, and (iv) neither multi-organ MRI nor digital rehabilitation (usual care); cluster randomizing at primary care network (PCN) level to deliver interventions as ‘standard of care’ in that area. The primary endpoint was mean Fatigue Assessment Scale (FAS) at 12 weeks. Secondary endpoints included FAS at 24 weeks and EQ-5D-5L visual assessment scale at 12 and 24 weeks. A total of 1,152 participants from allocated PCNs consented to data collection, and 122 PCN clusters were allocated to the multi-organ MRI (33 PCNs), digital rehabilitation (32 PCNs), ‘both’ (27 PCNs) and ‘neither’ (30 PCNs) arms. Baseline FAS was equivalent across groups (mean 35.8, s.d. 8.21, 66.4% female). Overall, the primary outcome was achieved in all arms, with scores improving by 4.5 points to 31.3 (s.d. 9.31) at 12 weeks. Compared with usual care, effects on 12-week FAS were −0.18 (95% confidence interval −0.72, 1.09; <i>P</i> = 0.69) with multi-organ MRI; −0.53 (−1.42, 0.36; <i>P</i> = 0.25) with digital rehabilitation; and −0.17 (−1.06, 0.72; <i>P</i> = 0.71) with their interaction. Absolute differences for other interventions from usual care were modest. There were no serious adverse events related to ICP interventions. Multidisciplinary holistic clinical care is associated with fatigue reduction in LC, irrespective of multi-organ MRI. Digital rehabilitation could be useful in longer-term LC management. Large, multi-site trials of optimal ICP interventions are feasible, but further trials are required. ISRCTN identifier: <a href="http://www.isrctn.com/ISRCTN10665760">ISRCTN10665760</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月28日

查看全文
  • Amitava Banerjee,
  • Gordon Prescott,
  • Emma Wall,
  • Caroline L. Watkins,
  • Melissa Heightman,
  • Alison Gibbon,
  • Al-Tahoor Butt,
  • Amanpreet Sarna,
  • Amir Manzelat,
  • Anand Viswanathan,
  • Andrea Dennis,
  • Andrew Clegg,
  • Andrew Williams,
  • Angela Green,
  • Annalisa Parabita,
  • Antony Loveless,
  • Anu Chandra,
  • Ashkan Dashtban,
  • Charles Latchford,
  • Charlotte Adams-Heath,
  • Chris Robson,
  • Christina M. van der Feltz-Cornelis,
  • Christopher Brown,
  • Claire Hooper,
  • Dan Cuthbertson,
  • Dan Wootton,
  • William David Strain,
  • David Sunkersing,
  • Deepak Ravindran,
  • Denise Forshaw,
  • Donna Clutterbuck,
  • Eamonn Foley,
  • Elena Bax,
  • Elizabeth Murray,
  • Emily Attree,
  • Emily Fraser,
  • Emma Mi,
  • Fauzia Begum,
  • Florence Mutesva,
  • Francesco Gambino,
  • Gail Allsopp,
  • Gregory Y. H. Lip,
  • Hakim-Moulay Dehbi,
  • Han-I Wang,
  • Helen Grice,
  • Henry Goodfellow,
  • Hugh Montgomery,
  • Ileana L. Selejan,
  • Jagdeep Sahota,
  • Jai Prashar,
  • Janet Scott,
  • Jasmine Hayer,
  • Jennifer Sweetman,
  • Joanna Peel,
  • Joanna Wright,
  • Jonathan Waywell,
  • Josie Newton,
  • Kamlesh Khunti,
  • Keri Hildick,
  • Kim Horstmanshof,
  • Kiran Khan,
  • Kumaran Balasundaram,
  • Laura Pasea,
  • Lauren O’Mahoney,
  • Lere Fisher,
  • Lyth Hishmeh,
  • Mag Leahy,
  • Manuel Gomes,
  • Marija Pantelic,
  • Mark Gabbay,
  • Matthew Robert Burns,
  • Maya Leach,
  • Mel Ramasawmy,
  • Michael Crooks,
  • Michael Zandi,
  • Mohamed Mohamed,
  • Nataliia Kryvutenko,
  • Natalie Smith,
  • Nefyn Williams,
  • Nisreen A. Alwan,
  • Ondine Sherwood,
  • Pablo Fernandez Medina,
  • Paula Lorgelly,
  • Phil Cumberlidge,
  • Rachael A. Evans,
  • Rachel Botell,
  • Rachel Hext,
  • Rachel Nyam,
  • Rachel Williams,
  • Rajarshi Banerjee,
  • Rebecca Livingston,
  • Rita Mallinson,
  • Robert Bell,
  • Rob Suriano,
  • Samantha Eccles,
  • Sarah Clegg,
  • Sophie Burchell-Kirk,
  • Sophie Equi,
  • Stephen Cone,
  • Terence Elliott-Cooper,
  • Toby Hillman,
  • Tushy Kailayanathan,
  • Valerio Benedetto,
  • Yi Mu

摘要

Combining multidisciplinary care plans into integrated care pathways (ICPs) is scalable, generalizable and effective for several long-term conditions, but not evaluated in Long COVID (LC). Our phase 3, cluster-randomized, multicenter clinical trial investigated the effectiveness of ICP interventions for LC. Recruitment of adults ≥18 years with LC was conducted in 6 National Health Service LC clinics in England with specialist ICPs. The intervention arms were (i) multi-organ magnetic resonance imaging (MRI; Coverscan), (ii) digital rehabilitation (Living with COVID Recovery), (iii) both multi-organ MRI and digital rehabilitation, and (iv) neither multi-organ MRI nor digital rehabilitation (usual care); cluster randomizing at primary care network (PCN) level to deliver interventions as ‘standard of care’ in that area. The primary endpoint was mean Fatigue Assessment Scale (FAS) at 12 weeks. Secondary endpoints included FAS at 24 weeks and EQ-5D-5L visual assessment scale at 12 and 24 weeks. A total of 1,152 participants from allocated PCNs consented to data collection, and 122 PCN clusters were allocated to the multi-organ MRI (33 PCNs), digital rehabilitation (32 PCNs), ‘both’ (27 PCNs) and ‘neither’ (30 PCNs) arms. Baseline FAS was equivalent across groups (mean 35.8, s.d. 8.21, 66.4% female). Overall, the primary outcome was achieved in all arms, with scores improving by 4.5 points to 31.3 (s.d. 9.31) at 12 weeks. Compared with usual care, effects on 12-week FAS were −0.18 (95% confidence interval −0.72, 1.09; P = 0.69) with multi-organ MRI; −0.53 (−1.42, 0.36; P = 0.25) with digital rehabilitation; and −0.17 (−1.06, 0.72; P = 0.71) with their interaction. Absolute differences for other interventions from usual care were modest. There were no serious adverse events related to ICP interventions. Multidisciplinary holistic clinical care is associated with fatigue reduction in LC, irrespective of multi-organ MRI. Digital rehabilitation could be useful in longer-term LC management. Large, multi-site trials of optimal ICP interventions are feasible, but further trials are required. ISRCTN identifier: ISRCTN10665760.